Noema Pharma

About:

Noema Pharma is a biotech company that develops therapies to address disabling symptoms in conditions of the brain and nervous system.

Website: https://noemapharma.com/

Top Investors: Invus, Polaris Partners, UPMC Enterprises, Forbion Capital Partners, Sofinnova Partners

Description:

Noema Pharma is a biotech company developing groundbreaking therapies to address the most disabling symptoms in orphan conditions of the brain and nervous system. Noema’s research and development is focused on understanding and meeting patient needs using their novel therapies. Noema Pharma was founded in 2019 and is based in Basel-Stadt, Switzerland.

Total Funding Amount:

157M CHF

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Basel, Basel-Stadt, Switzerland

Founded Date:

2019-01-01

Contact Email:

info(AT)noemapharma.com

Founders:

George Garibaldi, Luigi Costa

Number of Employees:

11-50

Last Funding Date:

2023-03-07

IPO Status:

Private

Industries:

© 2025 bioDAO.ai